Paper Details

  1. Home
  2. Paper Details

Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthma.

Author: AndersonDebbie E, BoyterAnne C, EvansDavid J W, KewKayleigh M

Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Long-acting muscarinic antagonists (LAMA) may be a safe and effective add-on option for adults with asthma who are uncontrolled on inhaled corticosteroids.
Paper Details　
Original Abstract of the Article :
Long-acting muscarinic antagonists (LAMA), a class of drugs with proven effectiveness in chronic obstructive pulmonary disease (COPD), are being considered as an add-on option for adults with asthma whose condition is uncontrolled on inhaled corticosteroids (ICS). It is important to assess the safet...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666143/

データ提供：米国国立医学図書館（NLM）

Long-Acting Muscarinic Antagonists (LAMA): A New Frontier for Asthma Treatment

This study investigates the potential of long-acting muscarinic antagonists (LAMA), a class of drugs typically used for chronic obstructive pulmonary disease (COPD), as an add-on therapy for adults with asthma. Asthma management often involves inhaled corticosteroids (ICS), but some individuals may experience undesirable side effects from long-term use of high doses. The researchers aimed to evaluate the safety and efficacy of LAMA as an alternative to higher dose ICS in managing uncontrolled asthma.

Exploring New Options for Asthma Management

The research suggests that LAMA, when added to ICS, could provide a valuable alternative to increasing ICS doses. The study found that LAMA add-on therapy effectively controlled asthma symptoms while potentially reducing the need for higher doses of ICS.

Managing Asthma with Precision

The findings offer a promising avenue for personalized asthma management. By considering LAMA as an add-on option, healthcare providers can potentially tailor treatment plans to minimize the risk of side effects associated with high-dose ICS.

Dr. Camel's Conclusion

Imagine a camel traversing a desert, seeking a safe and effective path to reach its destination. LAMA, when added to ICS, acts like a clever detour, helping asthma patients achieve optimal symptom control while minimizing the potential downsides of high-dose ICS.
Date :
  1. Date Completed 2016-02-09
  2. Date Revised 2023-11-08
Further Info :

Pubmed ID

26196545

DOI: Digital Object Identifier

PMC8666143

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.